How To Choose Clinical Sites In China (Part 2)
This article was originally published in PharmAsia News
The situation for clinical trials at the execution level in China is very different from that in developed countries, given that sites are in hospitals and must be GCP-certified by the China FDA. Due to the limitations of study professionals, site management organizations have emerged as the solution to serve the rapidly increasing number of trials in the country following health care and regulatory reforms.
Register for our free email digests: